biostudies-literatureChoi SNational Institute of Neurological Disorders and StrokeNINDS NIH HHS941-951https://www.ebi.ac.uk/biostudies/studies/S-EPMC10754232biostudies-literatureUnknown59(3)<h4>Background</h4>Paramagnetic rim lesions (PRLs) are associated with chronic inflammation in multiple sclerosis (MS). 7-Tesla (7T) magnetic resonance imaging (MRI) can evaluate the integrity of the blood-brain barrier (BBB) in addition to the tissue myelination status and cell loss.<h4>Purpose</h4>To use MRI metrics to investigate underlying physiology and clinical importance of PRLs.<h4>Study type</h4>Prospective.<h4>Subjects</h4>Thirty-six participants (mean-age 47, 23 females, 13 males) of mixed MS subtypes.<h4>Field strength/sequence</h4>7T, MP2RAGE, MULTI-ECHO 3D-GRE, FLAIR.<h4>Assessment</h4>Lesion heterogeneity; longitudinal changes in lesion counts; comparison of T1, R2*, and χ; association between baseline lesion types and disease progression (2-3 annual MRI visits with additional years of annual clinical follow-up).<h4>Statistical tests</h4>Two-sample t-test, Wilcoxon Rank-Sum test, Pearson's chi-square test, two-group comparison with linear-mixed-effect model, mixed-effect ANOVA, logistic regression. P-values <0.05 were considered significant.<h4>Results</h4>A total of 58.3% of participants had at least one PRL at baseline. Higher male proportion in PRL+ group was found. Average change in PRL count was 0.20 (SD = 2.82) for PRLs and 0.00 (SD = 0.82) for mottled lesions. Mean and median pre-/post-contrast T1 were longer in PRL+ than in PRL-. No differences in mean χ were seen for lesions grouped by PRL (P = 0.310, pre-contrast; 0.086, post-contrast) or PRL/M presence (P = 0.234, pre-contrast; 0.163, post-contrast). Median χ were less negative in PRL+ and PRL/M+ than in PRL- and PRL/M-. Mean and median pre-/post-contrast R2* were slower in PRL+ compared to PRL-. Mean and median pre-/post-contrast R2* were slower in PRL/M+ than in PRL/M-. PRL presence at baseline was associated with confirmed EDSS Plus progression (OR 3.75 [1.22-7.59]) and PRL/M+ at baseline with confirmed EDSS Plus progression (OR 3.63 [1.14-7.43]).<h4>Data conclusion</h4>Evidence of BBB breakdown in PRLs was not seen. Quantitative metrics confirmed prior results suggesting greater demyelination, cell loss, and possibly disruption of tissue anisotropy in PRLs.<h4>Evidence level</h4>2 TECHNICAL EFFICACY: Stage 2.Journal of magnetic resonance imaging : JMRIEvaluation of the Blood-Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI.PMC107542321K23NS072366-01A11R01NS104403-01R01 NS1044031K23NS072366‐01A11R01NS104403‐01K23 NS072366Choi SHarrison DMLake SfalseEvaluation of the Blood-Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI.<h4>Background</h4>Paramagnetic rim lesions (PRLs) are associated with chronic inflammation in multiple sclerosis (MS). 7-Tesla (7T) magnetic resonance imaging (MRI) can evaluate the integrity of the blood-brain barrier (BBB) in addition to the tissue myelination status and cell loss.<h4>Purpose</h4>To use MRI metrics to investigate underlying physiology and clinical importance of PRLs.<h4>Study type</h4>Prospective.<h4>Subjects</h4>Thirty-six participants (mean-age 47, 23 females, 13 males) of mixed MS subtypes.<h4>Field strength/sequence</h4>7T, MP2RAGE, MULTI-ECHO 3D-GRE, FLAIR.<h4>Assessment</h4>Lesion heterogeneity; longitudinal changes in lesion counts; comparison of T1, R2*, and χ; association between baseline lesion types and disease progression (2-3 annual MRI visits with additional years of annual clinical follow-up).<h4>Statistical tests</h4>Two-sample t-test, Wilcoxon Rank-Sum test, Pearson's chi-square test, two-group comparison with linear-mixed-effect model, mixed-effect ANOVA, logistic regression. P-values <0.05 were considered significant.<h4>Results</h4>A total of 58.3% of participants had at least one PRL at baseline. Higher male proportion in PRL+ group was found. Average change in PRL count was 0.20 (SD = 2.82) for PRLs and 0.00 (SD = 0.82) for mottled lesions. Mean and median pre-/post-contrast T1 were longer in PRL+ than in PRL-. No differences in mean χ were seen for lesions grouped by PRL (P = 0.310, pre-contrast; 0.086, post-contrast) or PRL/M presence (P = 0.234, pre-contrast; 0.163, post-contrast). Median χ were less negative in PRL+ and PRL/M+ than in PRL- and PRL/M-. Mean and median pre-/post-contrast R2* were slower in PRL+ compared to PRL-. Mean and median pre-/post-contrast R2* were slower in PRL/M+ than in PRL/M-. PRL presence at baseline was associated with confirmed EDSS Plus progression (OR 3.75 [1.22-7.59]) and PRL/M+ at baseline with confirmed EDSS Plus progression (OR 3.63 [1.14-7.43]).<h4>Data conclusion</h4>Evidence of BBB breakdown in PRLs was not seen. Quantitative metrics confirmed prior results suggesting greater demyelination, cell loss, and possibly disruption of tissue anisotropy in PRLs.<h4>Evidence level</h4>2 TECHNICAL EFFICACY: Stage 2.2024-01-01T00:00:00Z2024 Mar2025-04-04T01:12:31.268Z2025-04-04T01:12:31.268ZS-EPMC107542323727605410.1002/jmri.28847